In July 2021, the FDA issued Ardelyx a Complete Response Letter in which it stated that the molecules effect size was small and of unclear clinical significance. Then, in November 2022, an FDA advisory committee voted 9-4 that Xphozahs benefits outweighed its risks
It is also responsible for less severe side effects, such as gastrointestinal discomfort
GLP-1 Guide Evidence-first GLP-1 drugs and research compounds like semaglutide, tirzepatide, and retatrutide curb appetite, which can leave gaps in protein and key nutrients
Average 15-21% weight loss* Tailored programmes built by real experts Targeted support to make success feel simpler Unique app with weight loss tools and lessons Your journey starts here Start your personalised weight loss plan in minutes
According to Antlerzz, online searches for the GLP-1 semaglutide injection, which was originally intended for type 2 diabetes management, rose 170% in the U.S